PoniardNeoRx Corporation is changing its name to Poniard Pharmaceuticals, Inc. effective 5 p.m. PT June 16, 2006

SEC Filings

Add to Briefcase = Add Filing to Briefcase
     
Filing Description Date Filed Sorted Descending Size  
10-Q quarterly report Nov 6, 2008 206.1 KB Add to Briefcase
8-K current report Nov 3, 2008 63.1 KB Add to Briefcase
8-K current report Oct 6, 2008 40.8 KB Add to Briefcase
CT ORDER confidential treatment order Sep 26, 2008 12.7 KB Add to Briefcase
8-K current report Sep 8, 2008 392.9 KB Add to Briefcase
10-Q quarterly report Aug 7, 2008 205.0 KB Add to Briefcase
8-K current report Aug 4, 2008 67.0 KB Add to Briefcase
4 simon, nicholas j iii Jun 25, 2008 24.2 KB Add to Briefcase
4 stevens, david r Jun 25, 2008 23.9 KB Add to Briefcase
4 littauer, robert k Jun 25, 2008 23.9 KB Add to Briefcase
4 goldfischer, carl Jun 25, 2008 24.0 KB Add to Briefcase
4 dickson, e rolland Jun 25, 2008 24.6 KB Add to Briefcase
4 craves, fred b Jun 25, 2008 24.0 KB Add to Briefcase
4 basso, robert s Jun 25, 2008 24.0 KB Add to Briefcase
8-K current report Jun 5, 2008 80.3 KB Add to Briefcase
DEF 14A definitive proxy statement May 29, 2008 293.6 KB Add to Briefcase
10-Q quarterly report May 8, 2008 1.3 MB Add to Briefcase
8-K current report May 8, 2008 87.3 KB Add to Briefcase
8-K current report Mar 27, 2008 42.5 KB Add to Briefcase
10-K annual report Mar 14, 2008 958.6 KB Add to Briefcase
Showing 1-20 of 614 filings Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31  See Next 20

Stock Information
PARD - (NASD)
$2.52   - 0.37
Nov 21, 2008
4:00 PM ET

Quotes delayed at least 20 minutes. Information provided by eSignal.

About Poniard | Programs | Clinical Trials | Investors | News & Events | Contact